Intervention Review

Sertindole for schizophrenia

  1. Ruth Lewis1,*,
  2. Anne-Marie Bagnall2,
  3. Maria Leitner3

Editorial Group: Cochrane Schizophrenia Group

Published Online: 20 JUL 2005

Assessed as up-to-date: 24 MAY 2005

DOI: 10.1002/14651858.CD001715.pub2


How to Cite

Lewis R, Bagnall AM, Leitner M. Sertindole for schizophrenia. Cochrane Database of Systematic Reviews 2005, Issue 3. Art. No.: CD001715. DOI: 10.1002/14651858.CD001715.pub2.

Author Information

  1. 1

    Cardiff University, Department of Primary Care and Public Health, Wrexham, UK

  2. 2

    Leeds Metropolitan University, Faculty of Health, Leeds, UK

  3. 3

    University of Liverpool, Faculty of Medicine, Liverpool, UK

*Ruth Lewis, Department of Primary Care and Public Health, Cardiff University, Centre for Health Sciences / North Wales Clinical School, School of Medicine, Gwenfro Building, Wrexham, LL13 7YP, UK. lewisr17@Cardiff.ac.uk.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 20 JUL 2005

SEARCH

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens

or

Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.